2252.HK
2252.HK
CNE100004QP1
MEDBOT-B
Loading chart...

Company Profile

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People's Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR'obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved in the distribution of surgical robot devices. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.

Related stocks

2675.HK
2675.HK • China
EDGE MEDICAL-B
33 HKD
1.64B USD
2697.HK
2697.HK • China
TH MEDICAL-B
183 HKD
1.2B USD
7799.TW
7799.TW • Taiwan
HERON NEUTRON MEDICAL CORP.
518 TWD
2.57B USD 1Y -14.7%
301363.SZ
301363.SZ • China
Mehow
15.52 CNY
1.85B USD 1Y -10.3%
300482.SZ
300482.SZ • China
WONDFO BIOTECH
16.74 CNY
1.17B USD 1Y -22%
688139.SS
688139.SS • China
QINGDAO HAIER BIOMEDICAL CO LTD
35.13 CNY
1.66B USD 1Y +4.9%
300529.SZ
300529.SZ • China
JAFRON
15.12 CNY
1.81B USD 1Y -31.8%
290650.KQ
290650.KQ • South Korea
L&C BIO
56,400 KRW
1.07B USD 1Y +13.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
81.6% p.a.
Max Drawdown (5Y)
-91.0%
Sharpe Ratio (5Y)
-0.21
Beta Factor
1.45
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 High valuation risk: Avg P/E of 83.0 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (81.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -91.0% in the extended horizon.
ende